Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Breast Cancer Res Treat. 2011 Feb 12;130(3):791–807. doi: 10.1007/s10549-011-1374-9

Table 7.

Arrestin2 multivariate analysis

Clinical array: Arr2
Multivariate analysis
Variable n HR P 95% CI
Age at diagnosis
 <50 89 1
 ≥50 271 1.461 0.049* 1.002–2.131
Race
 Caucasian 345 1
 Other 15 1.400 0.309 0.732–2.678
Tumor size
 x<2 cm 119 1
 2 cm ≤ x < 5 cm 175 1.586 0.014* 1.096–2.294
 5 cm ≤ x 66 2.937 <0.001*** 1.927–4.476
Nuclear grade
 1 54 1
 2 201 0.928 0.741 0.598–1.442
 3 105 1.138 0.593 0.708–1.828
ER status
 Negative 160 1
 Positive 200 0.774 0.147 0.547–1.094
PR status
 Negative 176 1
 Positive 184 0.985 0.926 0.713–1.359
Her2 subtype
 Negative 334 1
 Positive 26 1.457 0.230 0.788–2.694
Lymph node status
 Negative 157 1
 Positive 203 1.778 0.002** 1.237–2.554
Arr2
 Low 130 1.116 0.520 0.799–1.559
 High 230 1
*

P values <0.05

**

P values <0.01

***

P values <0.001